Physician profile
Nancy Lippman
NPI 1306991120
$851.66
in general payments reported to CMS, 2019-2025
21 companies · $132 in 2025
The $132 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.29 · 2020: $28.22 · 2021: $99.77 · 2022: $100 · 2023: $279 · 2024: $123 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $130.56 | 2019-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Kaleo, INC. | $123.55 | 2019-2024 | Auvi-Q |
| Sanofi Pasteur INC. | $68.92 | 2021-2024 | |
| Aytu Biopharma, INC. | $66.13 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.86 | 2022-2024 | |
| Sobi, INC | $46.18 | 2023 | |
| Cranial Technologies, INC | $33.56 | 2020-2025 | Doc Band |
| Inspire Medical Systems, INC. | $33.21 | 2025 | Inspire |
| Ironshore Pharmaceuticals INC. | $29.55 | 2022 | |
| Sanofi-Aventis U.S. LLC | $29.55 | 2025 | |
| Meridian Bioscience INC. | $28.89 | 2019 | |
| Neos Therapeutics, LP | $28.50 | 2023 | Adzenys Xr-Odt |
| Seqirus USA INC | $28.00 | 2025 | Flucelvax |
| Pfizer INC. | $24.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $22.84 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $22.48 | 2025 | Bexsero |
| Exeltis, USA INC. | $20.32 | 2021 | |
| Corium, LLC | $19.26 | 2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $18.02 | 2021 | |
| Tris Pharma INC | $17.53 | 2021 | |
| Phadia US INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Lippman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.